FDA-Approved Anti-Obesity Drugs in the United States

被引:116
|
作者
Daneschvar, Homayoun L. [1 ]
Aronson, Mark D. [1 ]
Smetana, Gerald W. [1 ]
机构
[1] Harvard Med Sch, Div Gen Med & Primary Care, Beth Israel Deaconess Med Ctr, Shapiro 621C,330 Brookline Ave, Boston, MA 02215 USA
来源
AMERICAN JOURNAL OF MEDICINE | 2016年 / 129卷 / 08期
关键词
Anti-obesity drugs; Obesity; Weight loss; Weight loss drugs; PLACEBO-CONTROLLED TRIAL; CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE; WEIGHT-LOSS; SMOKING-CESSATION; OBESE ADULTS; DOUBLE-BLIND; OVERWEIGHT ADULTS; SUSTAINED-RELEASE; RANDOMIZED-TRIAL; EATING-DISORDER;
D O I
10.1016/j.amjmed.2016.02.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity is a growing health problem in our society and its treatment has been challenging. In recent decades, several anti-obesity drugs have been withdrawn from the market because of reported and documented adverse effects. After years of interruption, the US Food and Drug Administration (FDA) has recently approved multiple new anti-obesity drugs. The majority of these medications are taken orally, and only one is administered subcutaneously. In this article, we review the efficacy, adverse effects, and mechanism of action of all 5 FDA-approved drugs. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:879.e1 / 879.e6
页数:6
相关论文
共 50 条
  • [1] Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications
    Halpern, Bruno
    Halpern, Alfredo
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (02) : 305 - 315
  • [4] Repurposing FDA-approved drugs for anti-aging therapies
    Snell, Terry W.
    Johnston, Rachel K.
    Srinivasan, Bharath
    Zhou, Hongyi
    Gao, Mu
    Skolnick, Jeffrey
    BIOGERONTOLOGY, 2016, 17 (5-6) : 907 - 920
  • [5] Repurposing FDA-approved drugs for anti-aging therapies
    Terry W. Snell
    Rachel K. Johnston
    Bharath Srinivasan
    Hongyi Zhou
    Mu Gao
    Jeffrey Skolnick
    Biogerontology, 2016, 17 : 907 - 920
  • [6] Safety of FDA-Approved drugs - Reply
    Friedman, MA
    Woodcock, J
    Lumpkin, MM
    Shuren, JE
    Hass, AE
    Thompson, LJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (24): : 2297 - 2298
  • [7] NONAPPROVED USES OF FDA-APPROVED DRUGS
    ANDERSON, BJ
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1970, 211 (10): : 1705 - &
  • [8] An analysis of FDA-approved drugs for oncology
    Kinch, Michael S.
    DRUG DISCOVERY TODAY, 2014, 19 (12) : 1831 - 1835
  • [9] OVERVIEW OF FDA-APPROVED ANTI CANCER DRUGS USED FOR TARGETED THERAPY
    Di Martino, S.
    Rainone, A.
    Troise, A.
    Di Paolo, M.
    Pugliese, S.
    Zappavigna, S.
    Grimaldi, A.
    Valente, D.
    WORLD CANCER RESEARCH JOURNAL, 2015, 2 (03)
  • [10] A review on synthesis of FDA-approved antipsychotic drugs
    Rani, Anjali
    Aslam, Mohd
    Pandey, Garima
    Pant, Bhaskara Nand
    TETRAHEDRON, 2023, 138